Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults (2020)

First Author: Ward H
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.08.12.20173690

Publication URI: http://dx.doi.org/10.1101/2020.08.12.20173690

Type: Preprint